SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000897101-19-000120
Filing Date
2019-02-14
Accepted
2019-02-14 12:09:32
Documents
1
Group Members
IBS TURNAROUND FUND, L.P., THE IBS TURNAROUND FUND (QP) (A LTD PARTNERSHIP), THE IBS OPPORTUNITY FUND, LTD., DAVID A. TAFT

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ibs190312_sc13g.htm SC 13G 219255
  Complete submission text file 0000897101-19-000120.txt   220849
Mailing Address ONE INTERNATIONAL PLACE 31ST FLOOR BOSTON MA 02110
Business Address ONE INTERNATIONAL PLACE 31ST FLOOR BOSTON MA 02110 (617) 310-5160
IBS CAPITAL LLC (Filed by) CIK: 0001414860 (see all company filings)

IRS No.: 261094312
Type: SC 13G

Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-521-3390
AgeX Therapeutics, Inc. (Subject) CIK: 0001708599 (see all company filings)

IRS No.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90737 | Film No.: 19603337
SIC: 2834 Pharmaceutical Preparations